| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
0.047 |
0.9 |
| mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |